Revance Therapeutics Inc (RVNC)

[DewDiligence]

RVNC fully-diluted shares @9/14/22=101.4M:

• 73.1M basic shares on the 6/30/22 balance sheet (https://www.sec.gov/ix?doc=/Archives/edgar/data/0001479290/000147929022000082/rvnc-20220630.htm#i95a959e23a9c4d189948f4c4848a428f_16 );

• 5.0M options and 5.2M shares of unvested restricted stock and RSUs (ibid p.47);

• 9.2M shares raised in the 9/13/22 public offering (#msg-169932214, #msg-169948101);

• 8.9M shares deriving from the convertible debt issued in Feb 2020.